Literature DB >> 221913

Detection of a nuclear antigen in Herpesvirus ateles-carrying marmoset lines by the acid-fixed nuclear binding technique.

S Ohno, J Luka, G Klein, M D Daniel.   

Abstract

In vitro binding of a Herpesvirus ateles (HVA)-associated soluble antigen to amphibian erythrocyte nuclei was demonstrated by the acid-fixed nuclear binding technique in combination with anticomplement immunofluorescence. Incubation of concentrated salt-extracted soluble antigens derived from HVA-carrying marmoset lines with methanol/acetic acid-fixed erythrocytes of frogs and salamanders resulted in a brilliant nuclear fluorescence after exposure to a live virus-boostered, anti-HVS-positive squirrel monkey serum. Anti-HVS-negative sera did not stain. The activity of the positive serum could be abosrbed completely with extracts of HVA-carrying cells but not with Epstein-Barr virus-carrying or Herpesvirus papio-carrying cells. The HVA-associated antigen was also present in lytically HVA-infected marmoset kidney cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221913      PMCID: PMC383530          DOI: 10.1073/pnas.76.4.2042

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  PRODUCTION OF "TUMOR-SPECIFIC" ANTIGENS BY ONCOGENIC VIRUSES DURING ACUTE CYTOLYTIC INFECTIONS.

Authors:  M D HOGGAN; W P ROWE; P H BLACK; R J HUEBNER
Journal:  Proc Natl Acad Sci U S A       Date:  1965-01       Impact factor: 11.205

2.  Serological reactivities of human and baboon sera against EBNA and Herpesvirus papio-determined nuclear antigen (HUPNA).

Authors:  S Ohno; J Luka; L A Falk; G Klein
Journal:  Eur J Cancer       Date:  1978-09       Impact factor: 9.162

3.  Solubilization of the Epstein-Barr virus-determined nuclear antigen and its characterization as a DNA-binding protein.

Authors:  J Luka; W Siegert; G Klein
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

4.  The binding site on SV40 DNA for a T antigen-related protein.

Authors:  R Tjian
Journal:  Cell       Date:  1978-01       Impact factor: 41.582

5.  Transformation of lymphocytes by Herpesvirus papio.

Authors:  L A Falk; G Henle; W Henle; F Deinhardt; A Schudel
Journal:  Int J Cancer       Date:  1977-08-15       Impact factor: 7.396

6.  Characterization of polyoma virus T antigen.

Authors:  Y Ito; N Spurr; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

7.  Study of Epstein-Barr virus-determined nuclear antigen (EBNA) by chromatography on fixed cell nuclei.

Authors:  I Hirsch; A Suchánková; H Závadová; V Vonka
Journal:  Int J Cancer       Date:  1978-11-15       Impact factor: 7.396

8.  Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus.

Authors:  L Falk; F Deinhardt; M Nonoyama; L G Wolfe; C Bergholz
Journal:  Int J Cancer       Date:  1976-12-15       Impact factor: 7.396

9.  Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes.

Authors:  S Ohno; J Luka; T Lindahl; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  Detection of a nuclear, EBNA-type antigen in apparently EBNA-negative Herpesvirus papio (HVP)-transformed lymphoid lines by the acid-fixed nuclear binding technique.

Authors:  S Ohno; J Luka; L Falk; G Klein
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

View more
  4 in total

1.  No activation of new initiation points for deoxyribonucleic acid replication in BALB/c 3T3 cells transformed by Kirsten sarcoma virus.

Authors:  A Oppenheim; A T Horowitz
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  Initiation points for cellular deoxyribonucleic acid replication in human lymphoid cells converted by Epstein-Barr virus.

Authors:  A Oppenheim; Z Shlomai; H Ben-Bassat
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

3.  Analysis of herpesvirus saimiri structural proteins with monoclonal antibodies.

Authors:  J E Dahlberg; E Zintz; D V Ablashi
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Virus-specific transcription in a Herpesvirus saimiri-transformed lymphoid tumor cell line.

Authors:  E Knust; W Dietrich; B Fleckenstein; W Bodemer
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.